HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kaushal, K. Articles by Wareham, N. J. Search for Related Content PubMed PubMed Citation Articles by Kaushal, K. Articles by Wareham, N. J. Social Bookmarking                What's this?

The Impact of Abnormalities in IGF and Inflammatory Systems on the Metabolic Syndrome

¹ Department of Diabetes and Endocrinology, Hope Hospital, Stott Lane, Salford, U.K.
² Department of Paediatrics, Addenbrooke’s Hospital, University of Cambridge, Cambridge, U.K.
³ Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge, U.K.

Address correspondence and reprint requests to Dr. Adrian H. Heald, University Trust, Hope Hospital, Stott Lane, Salford M6 8HD, U.K. E-mail: aheald{at}fg1.ho.man.ac.uk

OBJECTIVE—Low plasma levels of IGF-I, particularly when coupled with low levels of the potentially inhibitory IGF binding protein (IGFBP)-1 and higher levels of C-reactive protein (CRP), have been implicated in the pathogenesis of metabolic syndrome X and cardiovascular disease. We report the relative contributions of IGFBP-1 and CRP to the occurrence of the metabolic syndrome in a healthy population cohort to establish the extent to which these factors may contribute to subsequent risk of cardiovascular disease.

RESEARCH DESIGN AND METHODS—The volunteers in the study were all participants in the Ely study, a continuing population-based cohort in Ely, Cambridgeshire, U.K. Of 839 individuals studied, 154 (18.4%) fulfilled criteria for the metabolic syndrome.

RESULTS—Subjects with the metabolic syndrome had lower IGFBP-1 (14.4 µg/l [95% CI 12.9–16.0] vs. 25.4 [24.1–26.7], P < 0.001) and higher CRP (1.9 mg/l [1.6–2.2] vs. 1.0 [0.9–1.1], P < 0.001). Logistic regression, adjusted for age, sex, fasting insulin, and IGF-I, demonstrated a striking 14-fold increased risk for the metabolic syndrome (odds ratio 14.1 [4.1–48.4], P < 0.001) in individuals with a CRP value in the highest tertile and IGFBP-1 levels below the median.

CONCLUSIONS—The combination of a high CRP concentration coupled with a low IGFBP-1 results in a dramatic increase in an individual’s risk of having the metabolic syndrome. Further elucidation of the biological processes linking the IGF and inflammatory systems may allow the identification of novel therapeutic targets for cardiovascular risk reduction.

Abbreviations: CRP, C-reactive protein • IGFBP, IGF binding protein • IL, interleukin • NEFA, nonesterified fatty acid • TNF, tumor necrosis factor

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. Succurro, F. Andreozzi, A. Sciaqua, M. L. Hribal, F. Perticone, and G. Sesti Reciprocal Association of Plasma IGF-1 and Interleukin-6 Levels With Cardiometabolic Risk Factors in Nondiabetic Subjects Diabetes Care, September 1, 2008; 31(9): 1886 - 1888. [Abstract] [Full Text] [PDF]

				G. Efstratiadis, G. Tsiaousis, V. G. Athyros, D. Karagianni, A. Pavlitou-Tsiontsi, A. Giannakou-Darda, and C. Manes Total Serum Insulin-like Growth Factor-1 and C-Reactive Protein in Metabolic Syndrome With or Without Diabetes Angiology, May 1, 2006; 57(3): 303 - 311. [Abstract] [PDF]

				K. Toutouzas, V. Markou, M. Drakopoulou, I. Mitropoulos, E. Tsiamis, M. Vavuranakis, S. Vaina, and C. Stefanadis Increased Heat Generation From Atherosclerotic Plaques in Patients With Type 2 Diabetes: An increased local inflammatory activation Diabetes Care, July 1, 2005; 28(7): 1656 - 1661. [Abstract] [Full Text] [PDF]